{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:09:32Z","timestamp":1775549372854,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,7]]},"DOI":"10.7759\/cureus.106563","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:23:56Z","timestamp":1775546636000},"source":"Crossref","is-referenced-by-count":0,"title":["Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Battuya","family":"Ganbold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayasgalan","family":"Purevdorj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariimaa","family":"Ganbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan CC","year":"2011","unstructured":"Chan CC, Rubenstein JL, Coupland SE, et al.. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011, 16:1589-99. 10.1634\/theoncologist.2011-0210","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.334","article-title":"Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma","volume":"131","author":"Salom\u00e3o DR","year":"2013","unstructured":"Salom\u00e3o DR, Pulido JS, Johnston PB, Canal-Fontcuberta I, Feldman AL. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. JAMA Ophthalmol. 2013, 131:1151-8. 10.1001\/jamaophthalmol.2013.334","journal-title":"JAMA Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12236","article-title":"Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma","volume":"92","author":"Riemens A","year":"2014","unstructured":"Riemens A, Missotten T, Baarsma S, et al.. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma. Acta Ophthalmol. 2014, 92:e159-60. 10.1111\/aos.12236","journal-title":"Acta Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101218","article-title":"Vitreoretinal lymphoma following primary testicular lymphoma: report of two cases and review of the literature","volume":"24","author":"Alsberge JB","year":"2021","unstructured":"Alsberge JB, Johnson RN. Vitreoretinal lymphoma following primary testicular lymphoma: report of two cases and review of the literature. Am J Ophthalmol Case Rep. 2021, 24:101218. 10.1016\/j.ajoc.2021.101218","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/carm\/7243012","article-title":"Choroidal recurrence of testicular diffuse large B-cell lymphoma: a diagnostic and therapeutic challenge in an immune-privileged site","volume":"2025","author":"Erol V","year":"2025","unstructured":"Erol V, Par\u00e7a O, Aslan NA, T\u00fcrk N\u015e. Choroidal recurrence of testicular diffuse large B-cell lymphoma: a diagnostic and therapeutic challenge in an immune-privileged site. Case Rep Med. 2025, 2025:7243012. 10.1155\/carm\/7243012","journal-title":"Case Rep Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01353-9","article-title":"Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging","volume":"20","author":"Fukutsu K","year":"2020","unstructured":"Fukutsu K, Namba K, Iwata D, et al.. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020, 20:94. 10.1186\/s12886-020-01353-9","journal-title":"BMC Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29020065","article-title":"Comprehensive laboratory diagnostic workup for patients with suspected intraocular lymphoma including flow cytometry, molecular genetics and cytopathology","volume":"29","author":"Shumilov E","year":"2022","unstructured":"Shumilov E, Mazzeo P, Zinkernagel MS, et al.. Comprehensive laboratory diagnostic workup for patients with suspected intraocular lymphoma including flow cytometry, molecular genetics and cytopathology. Curr Oncol. 2022, 29:766-76. 10.3390\/curroncol29020065","journal-title":"Curr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_883_25","article-title":"Ocular manifestations of systemic lymphoma","volume":"73","author":"Jiang T","year":"2025","unstructured":"Jiang T, Zhou X, Gu J, Chang Q. Ocular manifestations of systemic lymphoma. Indian J Ophthalmol. 2025, 73:1607-12. 10.4103\/IJO.IJO_883_25","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-014-3206-x","article-title":"Diagnostics and treatment of choroidal lymphoma (Article in German)","volume":"112","author":"Doycheva D","year":"2015","unstructured":"Doycheva D, Zierhut M, S\u00fcsskind D, Bartz-Schmidt KU, Deuter C. Diagnostics and treatment of choroidal lymphoma (Article in German). Ophthalmologe. 2015, 112:217-22. 10.1007\/s00347-014-3206-x","journal-title":"Ophthalmologe"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.05.024","article-title":"Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-erebral Lymphoma (LOC) Network","volume":"117","author":"Soussain C","year":"2019","unstructured":"Soussain C, Choquet S, Blonski M, et al.. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-erebral Lymphoma (LOC) Network. Eur J Cancer. 2019, 117:121-30. 10.1016\/j.ejca.2019.05.024","journal-title":"Eur J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.04.025","article-title":"Long-lasting CRS after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): long-term results of the Iloc study by the Lymphoma Study Association (LYSA) and the French oculo-cerebral lymphoma (LoC) network (clinical trial number: NCT02542514)","volume":"189","author":"Soussain C","year":"2023","unstructured":"Soussain C, Malaise D, Choquet S, Ghesqui\u00e8res H, Houillier C. Long-lasting CRS after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): long-term results of the Iloc study by the Lymphoma Study Association (LYSA) and the French oculo-cerebral lymphoma (LoC) network (clinical trial number: NCT02542514). Eur J Cancer. 2023, 189:112909. 10.1016\/j.ejca.2023.04.025","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00354-2","article-title":"Targeting Bruton's tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study","volume":"11","author":"Guan W","year":"2022","unstructured":"Guan W, Wang L, Peng X. Targeting Bruton's tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study. Exp Hematol Oncol. 2022, 11:95. 10.1186\/s40164-022-00354-2","journal-title":"Exp Hematol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479298-suspected-secondary-intraocular-lymphoma-with-choroidal-involvement-following-testicular-diffuse-large-b-cell-lymphoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:24:02Z","timestamp":1775546642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479298-suspected-secondary-intraocular-lymphoma-with-choroidal-involvement-following-testicular-diffuse-large-b-cell-lymphoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.106563","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}